Pradeep Bhadauria
Chief Tech/Sci/R&D Officer chez CIPLA LIMITED
Profil
Pradeep Bhadauria is currently the Global Chief Scientific Officer at Cipla Ltd.
He previously worked as the Chief Scientific Officer at Amneal Intermediate, Inc. Bhadauria received his graduate degree from Birla Institute of Technology & Science and his undergraduate degree from Shri Govindram Seksaria Institute of Technology & Science.
Postes actifs de Pradeep Bhadauria
| Sociétés | Poste | Début |
|---|---|---|
| CIPLA LIMITED | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Anciens postes connus de Pradeep Bhadauria
| Sociétés | Poste | Fin |
|---|---|---|
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | - |
Formation de Pradeep Bhadauria
| Birla Institute of Technology & Science | Graduate Degree |
| Shri Govindram Seksaria Institute of Technology & Science | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CIPLA LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Health Technology |
